Abstract
Ulcerative colitis (UC) is a chronic inflammatory bowel disease characterized by diffuse inflammation of the colorectal mucosa. Unlike Crohn’s disease, which has long been characterized as a progressive disease that results in bowel damage, the similarly progressive nature of UC has only more recently been considered and characterized by the extent of colonic involvement, development of neoplasia, altered colonic permeability, and dysmotility and anorectal dysfunction.1 Indirect support for these observations is found in the pivotal trials of therapies for UC, which demonstrate discrepancies between clinical remission and measures of mucosal healing.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
